Interaction of Cobalamin Status With Nitrous Oxide in Relation to Postoperative Cognitive Changes in the Elderly
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Low cobalamin (vitamin B12) levels are frequent in the elderly. Most often they reflect a mild metabolic abnormality without clinical symptoms (subclinical cobalamin deficiency). It is unclear if these elderly people require medical intervention, unlike that small minority with clinical symptoms which can progress and create severe blood or nervous system problems. The study aims to determine if nitrous oxide (N2O), a common anesthetic agent, worsens cobalamin status in elderly patients with unrecognized subclinical cobalamin deficiency. The reason for concern is that N2O inactivates cobalamin and can aggravate the clinical picture of patients who already have clinical manifestations of cobalamin deficiency. The elderly are known to have an increased risk of developing mental changes after surgery and it may be that sometimes these result from aggravation of subclinical cobalamin deficiency.
The study recruits people over the age of 60 years who are undergoing clinically indicated elective surgery requiring general anesthesia for more than 1 hour. Patients meeting exclusion and inclusion criteria are randomized to receive either a standard anesthetic regimen that includes N2O or a nearly identical one without N2O. Before surgery and 2 weeks and 4 weeks after surgery, each patient undergoes (1) a broad battery of tests of cognition and mood and (2) blood tests measuring cobalamin, folate and homocysteine-methionine metabolism to determine whether they have any subtle biochemical impairment of cobalamin status. DNA from blood cells is also tested for the presence of common mutations that affect key enzymes in those metabolic pathways. A brief testing for postoperative delirium is also done 2 hours after surgery.
The patient subgroups' are analyzed for neuropsychologic changes over time, using the preoperative test as the baseline for all comparisons, and associations of those changes with metabolic, genetic, demographic and clinical data.
The primary question is what effect routine N2O exposure has on the latter compared with non-N2O anesthesia in elderly people who either have or do not have subclinical cobalamin deficiency. It will help answer whether or not the combination can help explain the increased risk of cognitive problems after surgery in elderly patients, and by extension whether preoperative cobalamin testing and treatment may be indicated in the elderly. It will also test whether genetic predisposition affects the described problems.
| Condition | Intervention |
|---|---|
|
Avitaminosis Delirium, Dementia, Amnestic, Cognitive Disorders |
Drug: general anesthesia |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Diagnostic |
| Official Title: | Subtle Disturbances of Cobalamin Status |
- neuropsychologic performance changes [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]
- metabolic changes [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 444 |
| Study Start Date: | September 2003 |
| Study Completion Date: | August 2008 |
| Primary Completion Date: | August 2008 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: I
General anesthesia that includes nitrous oxide
|
Drug: general anesthesia
anesthesia regimen with nitrous oxide or without nitrous oxide
|
|
Active Comparator: II
General anesthesia not including nitrous oxide
|
Drug: general anesthesia
anesthesia regimen with nitrous oxide or without nitrous oxide
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 60 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- age >60 years; elective surgery requiring general anesthesia for an hour or more; English speaker
Exclusion Criteria:
- Surgery involving CNS, blood supply to head, or cardiovascular system; preexisting dementia, psychosis or stroke; contraindication to any of the planned anesthetic agents; exposure to nitrous oxide in past 6 months; clinical status other than ASA class 1 or 2; bronchospastic or chronic obstructive lung disease; use of cobalamin injections in past 6 months; serum creatinine >1.8 mg.
Contacts and Locations| United States, New York | |
| New York Methodist Hospital | |
| Brooklyn, New York, United States, 11215 | |
| WeillMedical College of Cornell University | |
| New York, New York, United States, 10021 | |
| Principal Investigator: | Ralph Carmel, MD | New York Methodist Hospital |
More Information
No publications provided
| Responsible Party: | Ralph Carmel - Principal Investigator, New York Methodist Hospital |
| ClinicalTrials.gov Identifier: | NCT00212147 History of Changes |
| Other Study ID Numbers: | DK32640 (completed) |
| Study First Received: | September 13, 2005 |
| Last Updated: | November 6, 2012 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
|
cobalamin anesthesia cognition |
Additional relevant MeSH terms:
|
Cognition Disorders Delirium Dementia Delirium, Dementia, Amnestic, Cognitive Disorders Avitaminosis Mental Disorders Confusion Neurobehavioral Manifestations Neurologic Manifestations Nervous System Diseases Signs and Symptoms Brain Diseases Central Nervous System Diseases Deficiency Diseases Malnutrition |
Nutrition Disorders Anesthetics Nitrous Oxide Hydroxocobalamin Vitamin B 12 Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions Central Nervous System Agents Therapeutic Uses Vitamin B Complex Vitamins Micronutrients Growth Substances Hematinics |
ClinicalTrials.gov processed this record on May 16, 2013